1
|
Li Z, Muench G, Wenhart C, Goebel S, Reimann A. Definition of a sectioning plane and place for a section containing hoped-for regions using a spare counterpart specimen. Sci Rep 2022; 12:13342. [PMID: 35922656 PMCID: PMC9349253 DOI: 10.1038/s41598-022-17380-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Accepted: 07/25/2022] [Indexed: 11/22/2022] Open
Abstract
Histological examination of targets in regions of interest in histological sections is one of the most frequently used tools in biomedical research. However, it is a technical challenge to secure a multitarget section for inspection of the structure’s mutual relationship of targets or a longitudinally filamentous- or tubular-formed tissue section for visitation of the overall morphological features. We present a method with a specified cutting plane and place, allowing researchers to cut directly at the multitarget centers accurately and quickly. The method is proven to be reliable with high accuracy and reproducibility and a low coefficient of variation, testing on repeat experiments of three target’s position-known models. With this method, we successfully yielded single sections containing whole intraorbital optical nerves, three aortic valves, or whole thoracic tracheas in their central positions. The adjoined custom-made tools used in the study, such as various tissue-specific formulated calibrated trimming and embedding guides, an organ-shaped cavity plaster mold, and a two-time embedding technique for optimal and identical trimming or embedding, also bear great potential to become a common supplemental tool for traditional histology and may contribute to the reduction of the labor, and the number of animals needed.
Collapse
Affiliation(s)
- Zhongmin Li
- Advancecor GmbH, Lochhamerstr. 29 A, 82152, Martinsried, Germany.
| | - Goetz Muench
- Advancecor GmbH, Lochhamerstr. 29 A, 82152, Martinsried, Germany
| | - Clara Wenhart
- Advancecor GmbH, Lochhamerstr. 29 A, 82152, Martinsried, Germany
| | - Silvia Goebel
- Advancecor GmbH, Lochhamerstr. 29 A, 82152, Martinsried, Germany
| | - Andreas Reimann
- Advancecor GmbH, Lochhamerstr. 29 A, 82152, Martinsried, Germany
| |
Collapse
|
2
|
Alyami W, Kyme A, Bourne R. Histological Validation of MRI: A Review of Challenges in Registration of Imaging and Whole-Mount Histopathology. J Magn Reson Imaging 2020; 55:11-22. [PMID: 33128424 DOI: 10.1002/jmri.27409] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Revised: 10/07/2020] [Accepted: 10/09/2020] [Indexed: 12/20/2022] Open
Abstract
Rigorous validation with ground truth information such as histology is needed to reliably assess the current and potential value of MRI techniques to characterize tissue and identify disease-related tissue alterations. Commonly used methods that aim to directly correlate histology and MRI data generally fall short of this goal due to spatial errors that preclude direct matching. Errors result from tissue deformation, differences in spatial resolution and slice thickness, non-coplanar and/or nonintersecting plane orientations, and different image contrast mechanisms. Some of these problems arise from limitations in standard protocols for clinical tissue processing and histology-based pathology reporting, and to some extent can be addressed by modifications to standard protocols without compromising the clinical process. Typical modifications include ex vivo specimen MRI, block-face photography, addition of fiducial markers, and 3D printed molds to constrain tissue deformation and guide sectioning. This review summarizes the advantages and limitations of MRI validation techniques based on coregistration of MRI with whole-mount histology of tissue specimens. LEVEL OF EVIDENCE: 4 TECHNICAL EFFICACY STAGE: 1.
Collapse
Affiliation(s)
- Wadha Alyami
- Discipline of Medical Imaging Science, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.,Discipline of Medical Imaging Science, Faculty of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia
| | - Andre Kyme
- School of Biomedical Engineering, Faculty of Engineering and IT, The University of Sydney, Sydney, New South Wales, Australia
| | - Roger Bourne
- Discipline of Medical Imaging Science, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
| |
Collapse
|
3
|
Wu HH, Priester A, Khoshnoodi P, Zhang Z, Shakeri S, Afshari Mirak S, Asvadi NH, Ahuja P, Sung K, Natarajan S, Sisk A, Reiter R, Raman S, Enzmann D. A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research. J Magn Reson Imaging 2018; 49:270-279. [PMID: 30069968 DOI: 10.1002/jmri.26189] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2018] [Accepted: 04/25/2018] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Patient-specific 3D-printed molds and ex vivo MRI of the resected prostate have been two important strategies to align MRI with whole-mount histopathology (WMHP) for prostate cancer (PCa) research, but the combination of these two strategies has not been systematically evaluated. PURPOSE To develop and evaluate a system that combines patient-specific 3D-printed molds with ex vivo MRI (ExV) to spatially align in vivo MRI (InV), ExV, and WMHP in PCa patients. STUDY TYPE Prospective cohort study. POPULATION Seventeen PCa patients who underwent 3T MRI and robotic-assisted laparoscopic radical prostatectomy (RALP). FIELD STRENGTH/SEQUENCES T2 -weighted turbo spin-echo sequences at 3T. ASSESSMENT Immediately after RALP, the fresh whole prostate specimens were imaged in patient-specific 3D-printed molds by 3T MRI and then sectioned to create WMHP slides. The time required for ExV was measured to assess impact on workflow. InV, ExV, and WMHP images were registered. Spatial alignment was evaluated using: slide offset (mm) between ExV slice locations and WMHP slides; overlap of the 3D prostate contour on InV versus ExV using Dice's coefficient (0 to 1); and 2D target registration error (TRE, mm) between corresponding landmarks on InV, ExV, and WMHP. Data are reported as mean ± standard deviation (SD). STATISTICAL TESTING Differences in 2D TRE before versus after registration were compared using the Wilcoxon signed-rank test (P < 0.05 considered significant). RESULTS ExV (duration 115 ± 15 min) was successfully incorporated into the workflow for all cases. Absolute slide offset was 1.58 ± 1.57 mm. Dice's coefficient was 0.865 ± 0.035. 2D TRE was significantly reduced after registration (P < 0.01) with mean (±SD of per patient means) of 1.9 ± 0.6 mm for InV versus ExV, 1.4 ± 0.5 mm for WMHP versus ExV, and 2.0 ± 0.5 mm for WMHP versus InV. DATA CONCLUSION The proposed system combines patient-specific 3D-printed molds with ExV to achieve spatial alignment between InV, ExV, and WMHP with mean 2D TRE of 1-2 mm. LEVEL OF EVIDENCE 2 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2019;49:270-279.
Collapse
Affiliation(s)
- Holden H Wu
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA.,Department of Bioengineering, University of California Los Angeles, Los Angeles, California, USA
| | - Alan Priester
- Department of Bioengineering, University of California Los Angeles, Los Angeles, California, USA.,Department of Urology, University of California Los Angeles, Los Angeles, California, USA
| | - Pooria Khoshnoodi
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA
| | - Zhaohuan Zhang
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA.,Department of Bioengineering, University of California Los Angeles, Los Angeles, California, USA
| | - Sepideh Shakeri
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA
| | - Sohrab Afshari Mirak
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA
| | - Nazanin H Asvadi
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA
| | - Preeti Ahuja
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA
| | - Kyunghyun Sung
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA.,Department of Bioengineering, University of California Los Angeles, Los Angeles, California, USA
| | - Shyam Natarajan
- Department of Bioengineering, University of California Los Angeles, Los Angeles, California, USA.,Department of Urology, University of California Los Angeles, Los Angeles, California, USA
| | - Anthony Sisk
- Department of Pathology, University of California Los Angeles, Los Angeles, California, USA
| | - Robert Reiter
- Department of Urology, University of California Los Angeles, Los Angeles, California, USA
| | - Steven Raman
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA.,Department of Urology, University of California Los Angeles, Los Angeles, California, USA
| | - Dieter Enzmann
- Department of Radiological Sciences, University of California Los Angeles, Los Angeles, California, USA
| |
Collapse
|
4
|
Accurate validation of ultrasound imaging of prostate cancer: a review of challenges in registration of imaging and histopathology. J Ultrasound 2018; 21:197-207. [PMID: 30062440 PMCID: PMC6113189 DOI: 10.1007/s40477-018-0311-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2018] [Accepted: 07/11/2018] [Indexed: 01/20/2023] Open
Abstract
As the development of modalities for prostate cancer (PCa) imaging advances, the challenge of accurate registration between images and histopathologic ground truth becomes more pressing. Localization of PCa, rather than detection, requires a pixel-to-pixel validation of imaging based on histopathology after radical prostatectomy. Such a registration procedure is challenging for ultrasound modalities; not only the deformations of the prostate after resection have to be taken into account, but also the deformation due to the employed transrectal probe and the mismatch in orientation between imaging planes and pathology slices. In this work, we review the latest techniques to facilitate accurate validation of PCa localization in ultrasound imaging studies and extrapolate a general strategy for implementation of a registration procedure.
Collapse
|
5
|
Priester A, Wu H, Khoshnoodi P, Schneider D, Zhang Z, Asvadi NH, Sisk A, Raman S, Reiter R, Grundfest W, Marks LS, Natarajan S. Registration Accuracy of Patient-Specific, Three-Dimensional-Printed Prostate Molds for Correlating Pathology With Magnetic Resonance Imaging. IEEE Trans Biomed Eng 2018; 66:14-22. [PMID: 29993431 DOI: 10.1109/tbme.2018.2828304] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
OBJECTIVE This investigation was performed to evaluate the registration accuracy between magnetic resonance imaging (MRI) and pathology using three-dimensional (3-D) printed molds. METHODS Tissue-mimicking prostate phantoms were manufactured with embedded fiducials. The fiducials were used to measure and compare target registration error (TRE) between phantoms that were sliced by hand versus phantoms that were sliced within 3-D-printed molds. Subsequently, ten radical prostatectomy specimens were placed inside molds, scanned with MRI, and then sliced. The ex vivo scan was used to assess the true location of whole mount (WM) slides relative to in vivo MRI. The TRE between WM and in vivo MRI was measured using anatomic landmarks. RESULTS Manually sliced phantoms had a 4.1-mm mean TRE, whereas mold-sliced phantoms had a 1.9-mm mean TRE. Similarly, mold-assisted slicing reduced mean angular misalignment around the left-right (LR) anatomic axis from 10.7° to 4.5°. However, ex vivo MRI revealed that excised prostates were misaligned within molds, including a mean 14° rotation about the LR axis. The mean in-plane TRE was 3.3 mm using molds alone and 2.2 mm after registration was corrected with ex vivo MRI. CONCLUSION Patient-specific molds improved accuracy relative to manual slicing techniques in a phantom model. However, the registration accuracy of surgically resected specimens was limited by their imperfect fit within molds. This limitation can be overcome with the addition of ex vivo imaging. SIGNIFICANCE The accuracy of 3-D-printed molds was characterized, quantifying their utility for facilitating MRI-pathology registration.
Collapse
|
6
|
De Roover R, Crijns W, Poels K, Peeters R, Draulans C, Haustermans K, Depuydt T. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer. Med Phys 2018. [PMID: 29537613 DOI: 10.1002/mp.12860] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
PURPOSE Liquid fiducial markers have shown to be a promising alternative to solid gold markers in terms of imaging artifact reduction, patient comfort, and compatibility with different imaging modalities. This study aims to investigate the performance of the novel BioXmark® liquid marker for state-of-the-art multimodal imaging used in prostate cancer (PCa) radiotherapy, encompassing kV CT/CBCT, multiparametric MRI, and kV x-ray imaging. In addition, automatic detection of the liquid markers in x-ray imaging for prostate motion monitoring during treatment was investigated. METHODS A total of eight BioXmark® liquid markers with varying volumes (range 5-300 μL) were casted on a square grid into a gelatin phantom insert. A cylindrical gold marker (QLRAD, length = 7 mm, Ø = 1 mm) was inserted for reference. Liquid marker visibility and streaking artifacts in CT/CBCT imaging were evaluated by placing the gelatin phantom into a CIRS anthropomorphic phantom. Relevant MRI characteristics such as the T2 and T1 relaxation times, the ADC value, and the relative proton density (ρH) were quantified by placing the gelatin phantom insert next to a T1MES mapping phantom and a water-filled syringe for reference. Ex vivo multiparametric MRI images were acquired by placing the gelatin phantom next to a resected prostate specimen. Anterior-posterior x-ray projection images were obtained by placing the gelatin phantom insert on top of an anthropomorphic pelvic phantom with internal pelvic bony structures and were acquired for five positions relative to the bony anatomy and 24 clinically relevant x-ray exposure settings. To quantify individual automatic marker detection, single markers were artificially isolated in the x-ray images using postprocessing. RESULTS Markers of all sizes were clearly visible on CT and CBCT images with only the largest marker volumes (100-300 μL) displaying artifacts similar in size to the gold fiducial marker. Artifact size increased with increasing liquid marker volume. Liquid markers displayed good contrast in ex vivo T1-weighted and ρH-weighted images. The markers were not visible in the ex vivo T2-weighted image. The liquid markers induced a chemical shift artifact in the obtained ADC-map. Automated detection in x-ray imaging was feasible with high detection success (four of five positions) for marker volumes in the range of 25-200 μL. None of the liquid markers were detected successfully when superimposed on a bony edge, independent of their size. CONCLUSIONS This study is the first to show the compatibility of BioXmark® liquid markers with multimodal image-guided radiotherapy for PCa. Compared to a solid gold marker, they had favorable results in both visibility and induced imaging artifacts. Liquid marker visibility in MRI imaging of the prostate does not solely depend on the low ρH value (not visible on T2-weighted image) but is also influenced by its relaxation times. Automated marker detection in x-ray images was feasible but better adapted marker detection algorithms are necessary for marker localization in the presence of bony edges. Hence, the liquid marker provides a minimally invasive (fine needles) and highly applicable alternative to current solid gold markers for multimodal image-guided prostate radiotherapy treatments.
Collapse
Affiliation(s)
- Robin De Roover
- Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven - University of Leuven, Herestraat 49, Leuven, B-3000, Belgium
| | - Wouter Crijns
- Department of Radiation Oncology, University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium
| | - Kenneth Poels
- Department of Radiation Oncology, University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium
| | - Ronald Peeters
- Department of Radiology, University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium
| | - Cédric Draulans
- Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven - University of Leuven, Herestraat 49, Leuven, B-3000, Belgium.,Department of Radiation Oncology, University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium
| | - Karin Haustermans
- Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven - University of Leuven, Herestraat 49, Leuven, B-3000, Belgium.,Department of Radiation Oncology, University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium
| | - Tom Depuydt
- Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven - University of Leuven, Herestraat 49, Leuven, B-3000, Belgium.,Department of Radiation Oncology, University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium
| |
Collapse
|